Epilepsy Trial, Recruiting (NCT04126369)

Epilepsy Trial, Recruiting NCT04126369 Sponsor: University Hospital, Grenoble Condition: Epilepsy

Printed from Voxsanity (voxsanity.com.au) — NCT04126369 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Epilepsy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have epilepsy that has not been well controlled by medication (also called drug-resistant epilepsy), as defined by international medical guidelines
Your epilepsy treatment has been stable and unchanged for at least 3 months
You do not have any planned surgery coming up
You are covered by social security health insurance or are a beneficiary of it
You are willing and able to sign a consent form agreeing to take part

Who may not be able to join:

You have previously done mindfulness practice or currently practice it regularly
Your seizures have been identified as psychological in nature rather than caused by electrical activity in the brain (confirm with trial site)
You are pregnant or currently breastfeeding
You are currently under a court order or administrative decision restricting your freedom, or you are under any form of legal protection (confirm with trial site)
You have mental health difficulties related to psychosis that affect how you relate to others
You are unable or unwilling to participate in group sessions, or you would have difficulty understanding the topics discussed during the sessions

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 04767656.9

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04126369

Sponsor: University Hospital, Grenoble

Phase: Not Applicable

Status: Recruiting

Condition: Epilepsy

Trial contact: 04767656.9

More information: https://clinicaltrials.gov/study/NCT04126369

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have epilepsy that has not been well controlled by medication (also called drug-resistant epilepsy), as defined by international medical guidelines
Your epilepsy treatment has been stable and unchanged for at least 3 months
You do not have any planned surgery coming up
You are covered by social security health insurance or are a beneficiary of it
You are willing and able to sign a consent form agreeing to take part

Who may not be able to join:

You have previously done mindfulness practice or currently practice it regularly
Your seizures have been identified as psychological in nature rather than caused by electrical activity in the brain (confirm with trial site)
You are pregnant or currently breastfeeding
You are currently under a court order or administrative decision restricting your freedom, or you are under any form of legal protection (confirm with trial site)
You have mental health difficulties related to psychosis that affect how you relate to others
You are unable or unwilling to participate in group sessions, or you would have difficulty understanding the topics discussed during the sessions

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University Hospital, Grenoble

Registry

ClinicalTrials.gov

Start date

20 January 2020

Est. completion

20 January 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Evolution of Quality Of Life In Epilepsy-Problems questionnaire (QOLIE31-P) score.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov